Servicios Personalizados
Revista
Articulo
Español (pdf)
Artículo en XML
Referencias del artículo
Traducción automática
Enviar artículo por emailIndicadores
Citado por SciELO 
Accesos
Links relacionados
Similares en
SciELO
Compartir
Permalink
Gaceta mexicana de oncología
versión On-line ISSN 2565-005Xversión impresa ISSN 1665-9201
Resumen
GARCIA-MANZANO, Roberto A. et al. Fibrolamelar hepatocarcinoma. Literature review and case report. Gac. mex. oncol. [online]. 2021, vol.20, suppl.1, pp.90-94. Epub 22-Ago-2022. ISSN 2565-005X. https://doi.org/10.24875/j.gamo.20000071.
Introduction:
Hepatocellular fibrolamellar carcinoma is rare, with unique pathogenesis (genomic, histological, clinical, and epidemiological). The curative treatment is surgical resection.
Case report:
A 27-year-old female with nonspecific right hypochondrium abdominal pain. Tomographic report: left liver lobe tumor, negative tumor markers; tumor resection with liver segments II, III and IVB is performed. Fibrolamellar hepatocarcinoma is reported. Patient is sent to an adjuvant therapy based on sorafenib.
Conclusion:
This type of hepatocarcinoma does not have established chemotherapy, despite the high possibility of relapse even with optimal surgical resection, which is why an early diagnosis is required.
Palabras llave : Fibrolamellar hepatocarcinoma; Liver tumor; Sorafenib.
